ELRIG Launch Drug Discovery ’13

6 Feb 2013

Industry news

ELRIG are now preparing for the 7th Annual Drug Discovery Conference, which will be held at Manchester Central on 3rd & 4th September 2013.

The 2013 programme will contain presentations from leading scientists across European Drug Discovery, covering innovations and advances in basic and translational aspects of drug discovery: covering topics such as Innovations in Assay Development, through Oncology Drug Discovery, Macromolecules, Safety & DMPK Screening, Sample Management, Stem Cells, and Stratified Medicine.

Each year, this conference provides a fantastic communication and learning opportunity for scientists engaged at the leading edge of drug discovery, whether in Academia, Biotech or Pharma.

As with our highly successful meeting in 2012, attendees will hear world class speakers discussing the challenges and opportunities facing drug discovery scientists today. Drug Discovery ’13 will include a scientific poster session, networking sessions, and a large vendor exhibition.

Links

Tags

ADME-ToxicologyADME-toxicology (ADME-Tox) studies are used in pharmacology and pharmacokinetics to assess the activity/toxicity of drugs <i>in vivo</i> or <i>in vitro</i>. Find bioassays for absorption, distribution, metabolism, and excretion of drug molecules including cytotoxicity, transporter/permeability, metabolism and activity assays as well as hepatocytes and cell lines for ADME. Find the best ADME-toxicology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.ELRIG
ELRIG Launch Drug Discovery ’13